IDL Composition and Angiographically Determined Progression of Atherosclerotic Lesions During Simvastatin Therapy

This publication has 19 references indexed in Scilit:

• Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS)
  The Lancet, 1994
• Independent associations between plasma lipoprotein subfraction levels and the course of coronary artery disease in the St. Thomas' Atherosclerosis Regression Study (STARS)
  Metabolism, 1993
• Quantitative angiographic and statistical methods to assess serial changes in coronary luminal diameter and implications for atherosclerosis regression trials
  The American Journal of Cardiology, 1992
• The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
  New England Journal of Medicine, 1992
• Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein B
  New England Journal of Medicine, 1990
• Pravastatin therapy in primary moderate hypercholesterolaemia: changes in metabolism of apolipoprotein B‐containing lipoproteins
  Journal of Internal Medicine, 1990
• INTERMEDIATE-DENSITY LIPOPROTEINS AND PROGRESSION OF CORONARY ARTERY DISEASE IN HYPERCHOLESTEROLAEMIC MEN
  The Lancet, 1987
• Presence of multiple subpopulations of lipoproteins of intermediate density in normal subjects.
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1986
• Evaluation of a new HDL2/HDL3 quantitation method based on precipitation with polyethylene glycol
  Clinica Chimica Acta; International Journal of Clinical Chemistry, 1985
• A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association
  Circulation, 1975